Posts Tagged ‘Matthew Sherwood’
Inova Heart and Vascular Institute Recruiting Patients for AFib Stroke Prevention Device Clinical Trial
Matthew W. Sherwood, MD, MHS, is an Inova interventional cardiologist, Director of Inova’s Left Atrial Appendage Closure/WATCHMAN Program and Co-Director of Inova’s Structural Heart Disease Program. Dr. Sherwood is board-certified in interventional cardiology, cardiovascular disease and internal medicine. Millions of Americans have atrial fibrillation (AFib) and take oral anticoagulant medication (blood thinners) every day. These…
Read MoreWhat is AFib? A Guide to Atrial Fibrillations Symptoms & Treatments
Matthew W. Sherwood, MD, MHS, is board-certified in interventional cardiology, cardiovascular disease and internal medicine. Marc H. Wish, MD, is board-certified in clinical cardiac electrophysiology and cardiovascular disease. Dr. Sherwood and Dr. Wish practice at the Inova Heart and Vascular Institute. Atrial fibrillation — commonly called AFib — is a heart rhythm problem that causes…
Read MoreInova Heart Team Tests New, Minimally Invasive Option to Replace Leaky Mitral Valves
Matthew W. Sherwood, MD, MHS, is board certified in interventional cardiology, cardiovascular disease and internal medicine. He practices at the Inova Heart and Vascular Institute. The Inova Heart and Vascular Institute has a long history as a leader in treating heart disease. True to that mission, we’re excited to offer an innovative new treatment for patients…
Read MoreThe GALILEO Trial: Inova Researchers Study New Drug Therapy for Heart Patients
Matthew W. Sherwood, MD, is board certified in interventional cardiology, cardiovascular disease and internal medicine. He practices at the Inova Heart and Vascular Institute. Read Dr. Sherwood’s profile. Starting in March, we began enrolling patients in a first-of-its-kind study to compare drug therapies for patients who have had transcatheter aortic valve replacement, or TAVR. As…
Read More